Lonzeal Pharmaceuticals is among the leading producers of antiretroviral drugs for treating HIV in China. Their current line of antiretroviral (ARV) products includes Lamivudine, Emtricitabine, Tenofovir, and their respective precursors. The active pharmaceutical ingredient (API) has obtained GMP certification from various drug regulatory agencies such as USFDA, WHO, China CFDA, and Brazil ANVISA, and is also registered in Russia, South Africa, and India. The company continuously exports to various destinations.
Lonzeal Pharmaceuticals
Headquarters
People's Republic of China